RED CROSS

Red Cross receives grant

Fort Wayne, Ind.  (WANE) -The American Red Cross is getting thousands of dollars in grant money from the Community Foundation of Greater Fort Wayne.… More »

This photo provided by Gilead Sciences, Inc. shows the drug Epclusa. Federal health officials on Tuesday, June 28, 2016, approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus. (Gilead Sciences, Inc. via AP)

FDA approves first pill to treat all forms of hepatitis C

The drug won’t be cheap. Epclusa will cost $74,760 for a 12-week course of treatment, or roughly $890 per pill. That’s less than the initial price for company’s previous drug, Harvoni, which cost $1,125 per pill.